The abstract is read at the publisher; the summary is JClub's.
Adults with autoimmune rheumatic diseases had a higher Long COVID prevalence (2.8% vs 1.5%) and increased risk (aHR 1.56, 95% CI 1.45–1.67) in a matched N3C cohort.
- Why it matters: Evidence is limited on how common Long COVID is and which factors raise risk in people with autoimmune rheumatic diseases, despite their immune-related vulnerabilities.
- What they did: Using N3C data, adults with first SARS-CoV-2 infection from September 2021 to December 2023 were followed through December 2024; Long COVID was defined by ICD-10-CM U09.9 or a Long COVID clinic visit 28–365 days later, with 1:1 propensity matching and multivariable Cox models.
- The result: Within AIRD patients, higher acute COVID-19 severity, pulmonary disease, obesity, and rituximab or glucocorticoid exposure were linked to increased Long COVID risk, and Sjögren’s syndrome was associated with higher risk.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.